The U.S. Food and Drug Administration has recently granted its first approval to an immunotherapy regimen for Triple Negative Breast Cancer, which is significant because Triple Negative Breast Cancer tumors are generally high-grade, aggressive, and typically more likely to spread and recur.
Read more on First Immunotherapy Regimen for Triple-Negative Breast Cancer Approved By FDA…
Read More Immunotherapy for breast cancer, Triple Negative breast cancer treatment
For women diagnosed with hormone-receptor-positive DCIS, a new study has determined that low dose Tamoxifen after surgery reduced the risk of the disease coming back. Low dose tamoxifen also reduced the risk of developing a new invasive breast cancer.
Read more on Low Dose Tamoxifen Reduces Risk Of Recurrence For Some Breast Cancers…
Read More ADH, ALH breast cancers, DCIS, LCIS, reduce breast cancer recurrence
Many patients assume that surgery is the first step towards treatment, and this is true in that doctors do typically recommend surgery to remove a tumor for both early-stage invasive breast cancer and DCIS.
Read more on Can Some Types Of Breast Cancer Be Cured Without Surgery?…
Read More her2-positive breast cancer, Triple Negative Breast Cancer
According to the American Cancer Society, pancreatic cancer is currently the third leading cause of cancer-related deaths in the U.S., and rates are rising faster than any other cancer in the country. Researchers predict it will become the second deadliest cancer in the U.S. by 2030, second only to lung cancer.
Read more on New Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk…
Read More BRCA gene, pancreatic cancer treatment, PARP-I
We hosted a dinner on PARP Inhibitors recently. PARP Inhibitors are a class of medications that may have benefits in Triple Negative and other Breast Cancers in women with a BRCA mutation. Homologous Recombination Deficiencies are associated with several cancers, including breast cancer, and can be identified in breast cancer tissue itself. Tumors with a homologous recombination deficiency (including BRCA mutations) are described as HRD-positive.
Read more on More Hope For PARP Inhibitors In Treating Breast Cancer…
Read More BRCA gene, HRD, PARP-I, Triple Negative Breast CancerYou’ve most likely seen the ads on TV for home-kits like 23andMe that can tell you about your ancestry through saliva testing. 23andMe is now offering the ability to give you FDA approved health reports as well, and people are curious if these reports can determine if they carry the BRCA1 and BRCA2 genes, which increase the risk of breast and ovarian cancer.
Read more on Concerns About Genetic Testing Kits For Detecting Breast Cancer Genes…
Read More Breast Cancer Genes, Detecting Breast Cancer Genes, Genetic testing, Genetic Testing Kits
The last week of September is National Hereditary Breast and Ovarian Cancer (HBOC) Week, and October 3rd is National Previvor Day. These are both important events to raise awareness about hereditary cancer and the importance of BRCA gene testing. Millions of people carry an inherited BRCA gene mutation or have a family history of cancer, but many remain unaware of their risk. National HBOC Week and Previvor Day aim to change that.
Read more on Why You Need To Know About HBOC Week and Previvor Day…
Read More breast cancer risk factors, Genetic testing, genetics and ovarian cancer
Breaking news in breast cancer research will affect whether or not a significant number of women with early-stage breast cancer can forgo chemotherapy. On June 3rd, at ASCO (the American Society of Clinical Oncology annual meeting) researchers presented their findings of a highly-anticipated study called the TAILORx trial, which followed almost 10,000 women with early-stage breast cancer.
Read more on Breakthrough Study Reveals Fewer Early-Stage Breast Cancer Patients Need Chemo…
Read More Breast Cancer Treatment, Chemotherapy, endocrine therapy
V. Suzanne Klimberg, M.D.
March 30th is National Doctors’ Day, which reminds me how grateful I am to one special doctor who helped me become the surgeon I am today. V. Suzanne Klimberg, M.D. was my mentor while I was in training at the University of Arkansas for Medical Sciences (UAMS) from 2004 to 2006.
Read more on A Tribute To My Mentor On National Doctors’ Day…
Read More breast cancer surgeons, Dr. V. Suzanne Klimberg
Real Men Wear Pink.
Pink is a color of health, as in “pink cheeks.” Pink is also a fighting color, as in a softer form of the warlike red. Real Men Wear Pink is a group of men uniting together to eradicate breast cancer and restore the health of millions of women.
Read more on Real Men Wear Pink While Making Strides to Cure Breast Cancer…
Read More